Business Wire

Mastering Complexity & Increasing Efficiency: CES 2026: dSPACE Demonstrates Test and AI Solutions for SDV Development

16.12.2025 15:02:00 EET | Business Wire | Press release

Share

At CES 2026, dSPACE will showcase end-to-end test solutions that enable vehicle manufacturers to efficiently master the increasing complexity in the development of software-defined vehicles. At booth 4500 in West Hall, dSPACE will present a comprehensive validation portfolio with AI-supported software-in-the-loop and hardware-in-the-loop solutions for accelerated vehicle development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216117958/en/

At CES 2026, dSPACE will present a comprehensive validation portfolio with AI-supported software-in-the-loop and hardware-in-the-loop solutions for accelerated SDV development.

AI is a strategic enabler throughout the entire development and test process. dSPACE has been exploring how the latest developments in generative and agentic AI technologies can support software-in-the-loop (SIL) testing and enable CI/CD pipelines for automated validation. In an exhibit, dSPACE will demonstrate a Visual Studio Code and GitHub Copilot solution for the automated generation of virtual ECUs for SIL tests.

SDV Development: CI/CT Pipeline Integration and Test Farm Management

Software-defined vehicles (SDVs) require significantly faster and more short-cycle development and validation. To meet these requirements, dSPACE is demonstrating a CI/CT concept demo at CES that presents a scalable, cloud-native validation approach. The demo includes a GitLab pipeline, which is highly automated and integrated with VEOS, the dSPACE SIL test software, and SCALEXIO, the dSPACE HIL test platform, enabling continuous testing over the entire development cycle.

dSPACE is presenting a HIL Farm Management Demo, designed to ensure reliable execution of these pipelines and increase test efficiency, especially in the HIL field. This transparently displays the availability and utilization of the HIL systems as well as potential system errors. The aim is to reduce system downtimes and improve the utilization of existing test resources.

From SIL to HIL: Testing E-Mobility Across the Board

To ensure efficient and cost-optimized validation throughout the entire development process in both SIL and HIL contexts, software tools, models, and test artifacts must be seamlessly integrated into all validation phases. At CES, dSPACE will use its test solutions for battery charging and battery management systems to demonstrate how test efficiency can be increased through end-to-end SIL/HIL validation if the same test cases, simulation models, bus and network configurations, and user interfaces can be reused for both methods. For example, dSPACE offers solutions for testing charging technologies and battery management systems, where all functions, including conformance tests with HIL and SIL implementations, can be demonstrated with the same layouts and test cases. Developers benefit from significantly increased efficiency, accelerated development, and higher software quality.

Product Launches: New Radar Solution, Cybersecurity Test Framework, and Cost-Effective HIL-System

With DARTS ARROW, dSPACE presents a new radar solution for functional testing of radar sensors. DARTS ARROW was specially developed for use in end-of-line tests and periodic technical inspections (PTI) of radar-based driver assistance systems. The robust and cost-effective system is suitable for validating safety-relevant driver assistance systems such as emergency braking, lane departure warning, and distance control assistants. By realistically simulating traffic scenarios under controlled conditions, sensor errors can be detected, and the functionality of safety-critical assistance systems can be ensured over the entire lifecycle.

dSPACE will also be presenting HydraVision – a scalable cybersecurity test framework for vehicle development. With an explorative approach and expandable test case templates, HydraVision enables the efficient integration of cybersecurity tests into the development process. This allows potential weak points to be identified, evaluated, and mitigated at an early stage. In this way, dSPACE supports manufacturers and suppliers in sustainably meeting the increasing safety requirements in the automotive industry.

The new SCALEXIO Essential system is an extension of the scalable dSPACE SCALEXIO real-time platform for hardware-in-the-loop testing. The system is designed for the development and validation of classic edge ECUs, particularly for mechatronic applications in the automotive, agricultural machinery, and construction machinery industries, and rounds off the HIL portfolio. SCALEXIO Essential comes with a fully-fledged software package. This means that the cost-efficient system is ready for immediate use.

dSPACE will be presenting its solutions at CES 2026 from January 6 to 9 in the Las Vegas Convention Center West Hall at booth 4500.

About dSPACE

dSPACE is the world's leading provider of simulation and validation solutions for developing connected, autonomous, and electrically powered vehicles. The company's end-to-end solutions are used in particular by automotive manufacturers and their suppliers to test the software and hardware components of their new vehicles long before a new model hits the road. dSPACE is not only a sought-after partner in vehicle development, but engineers also rely on our know-how in the fields of aerospace, agriculture, and industrial automation. Our portfolio ranges from end-to-end simulation and validation solutions to engineering and consulting services, training, and support. With over 2,900 employees worldwide, dSPACE has offices in Paderborn, Germany, four project centers in Germany, and serves customers through its regional companies in the USA, the UK, France, Japan, China, Croatia, South Korea, India, Sweden and Italy.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251216117958/en/

Contacts

dSPACE GmbH
Bernd Schäfers-Maiwald
Vice President, Corporate Marketing & Communications
Rathenaustrasse 26
33102 Paderborn
Tel.: +49 5251 1638-714
E-mail: bschaefers-maiwald@dspace.de

dSPACE GmbH
Ulrich Nolte
Communications Manager, Corporate Marketing & Communications
Rathenaustrasse 26
33102 Paderborn
Tel.: +49-5251-1638--1448
E-mail: unolte@dspace.de

dSPACE Inc--USA
Lisa Kuehl
Sr. Manager Marketing and Communications
50131 Pontiac Trail
Wixom, Michigan, 48393
E-mail: lkuehl@dspaceinc.com

press@dspace.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release

Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye